Tag Archive | "Gardasil"

HPV Vaccine Not Linked To Autoimmune Disorders, Study

Friday, February 3, 2012

0 Comments

Source: MedicalNewsToday.com A two-year study of nearly 190,000 girls and women, finds that Gardasil, the human papillomavirus (HPV) vaccine made by Merck & Co, does not trigger autoimmune disorders such as lupus, rheumatoid arthritis, type 1 diabetes and multiple sclerosis. The results are published in the Journal of Internal Medicine. Study lead author Dr Chun [...]

Continue reading...

Success of HPV vaccination is now a matter of coverage

Wednesday, January 4, 2012

0 Comments

Source: The Lancet Oncology, Volume 13, Issue 1, Pages 10-12, January 2012 In a pair of articles in The Lancet Oncology, Lehtinen and colleagues and Wheeler and colleagues present 4-year end of study data from a trial of a prophylactic human papillomavirus (HPV)-16/-18 vaccine (Cervarix, GlaxoSmithKline) in young women aged 15-25 years. From a public-health [...]

Continue reading...

Boys need the cervical cancer jab, too

Monday, December 5, 2011

0 Comments

Source: www.telegraph.co.uk Author: Max Pemberton Few politicians will ever admit they are wrong, so I salute health ministers who have finally capitulated to medical opinion and last month announced a U-turn on the cervical cancer vaccine that is given to 12- and 13-year-old girls. Until now, Cervarix, which protects against two strains of the human [...]

Continue reading...

HPV vaccine myths put health, lives at risk, say health leaders: Airing the facts

Thursday, December 1, 2011

0 Comments

Source: TheNationsHealth.org Vaccination rates for human papillomavirus are lagging for teens, and a complicated web of confusion and misinformation may be to blame, according to public health leaders. Several strains of HPV can cause cervical cancer, and two vaccines, Gardasil and Cervarix, have been shown conclusively to defend against those strains. The Food and Drug [...]

Continue reading...

Use and Acceptance of HPV Vaccine Still a Work in Progress

Wednesday, November 30, 2011

0 Comments

Source: National Cancer Institute A bellwether moment in the history of cancer prevention came in 2006 when the Food and Drug Administration (FDA) approved the first vaccine to prevent cervical cancer. The vaccine, Gardasil, protects against the two primary cancer-causing, or oncogenic, types of the human papillomavirus (HPV)—HPV-16 and HPV-18. These types are responsible for [...]

Continue reading...

HPV Vaccine Recommended for Boys aged 11 to 12 Years

Wednesday, October 26, 2011

0 Comments

Source: HemOncToday.com The CDC’s Advisory Committee on Immunization Practices today approved routine recommendation in favor of administering the quadrivalent HPV vaccine for boys aged 11 to 12 years. Committee members decided that the vaccine (Gardasil, Merck) was safe, efficacious and cost-effective enough to warrant routine usage in this population. The recommendation issued in 2009 was [...]

Continue reading...

CDC Committee Recommends Boys Receive HPV Vaccine

Tuesday, October 25, 2011

0 Comments

Source: CNN.com A federal government advisory committee voted Tuesday to recommend that boys and young men, from ages 11 to 21, be vaccinated against the human papilloma virus, commonly referred to as HPV. The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices says the vaccine series can be started as early as [...]

Continue reading...

Oral cancers on rise due to HPV

Saturday, October 15, 2011

0 Comments

Source: gargoyle.flagler.edu Author: staff Many Flagler College students are reconsidering human papillomavirus (HPV) vaccines due to the growing number of head and neck cancers in the United States caused by the HPV virus. According to a new study in the Journal of Clinical Oncology, the number of cases of oropharyngeal cancer, which are cancers of [...]

Continue reading...

Increase in oral cancers linked to HPV

Monday, October 3, 2011

1 Comment

Source: thechart.blogs.cnn.com Author: Saundra Young – CNN Medical Senior Producer The human papillomavirus is contributing to the growing number of head and neck cancers in the United States, according to a new study Monday in the Journal of Clinical Oncology. The study found that the number of cases of oropharyngeal cancer – cancers of the [...]

Continue reading...

New HPV Study Proves Vaccine’s Effectiveness

Tuesday, September 27, 2011

0 Comments

Source: Cancer.gov A flurry of new research findings on a vaccine that prevents persistent infections by cancer-causing types of the human papillomavirus (HPV) has confirmed the vaccine’s efficacy and opened new avenues for research. The results, published in three separate reports, suggest that the vaccine could be simpler to administer and more affordable than researchers [...]

Continue reading...